Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 2 3

Status

Completed 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1277Carcinoma, Non-Small-Cell Lung 926Prostatic Neoplasms 729Neoplasms 632Multiple Myeloma 553Lymphoma 539Colorectal Neoplasms 529Lung Neoplasms 515Leukemia 497Leukemia, Myeloid, Acute 472Neoplasm Metastasis 470Melanoma 425Lymphoma, Non-Hodgkin 417Ovarian Neoplasms 416Leukemia, Lymphocytic, Chronic, B-Cell 386Pancreatic Neoplasms 373Recurrence 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 327Head and Neck Neoplasms 306Lymphoma, Large B-Cell, Diffuse 294Glioblastoma 294Myelodysplastic Syndromes 287Brain Neoplasms 287Lymphoma, Follicular 286Stomach Neoplasms 280Carcinoma, Renal Cell 268Hodgkin Disease 261Carcinoma, Hepatocellular 261Rectal Neoplasms 256Sarcoma 250

Interventions

epigallocatechin gallate 1cabozantinib 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Frailty × Clear all
NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed
24 enrolled 17 charts

Frailty, Inflammation

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed
25 enrolled
Genitourinary

Frailty, Carcinoma, Renal Cell

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Baylor College of Medicine

Phase 2 Completed
44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡